Autres langues Creo Medical Group PLC

Actions

CREO

GB00BZ1BLL44

Temps Différé London S.E. Autres places de cotation 12:54:17 29/04/2024			Varia. 5j.	Varia. 1 janv.
36 ^GBX	-0,69 %		+3,60 %	-21,74 %

24/04	Augmentation des ventes d'ActiveOps et hausse du chiffre d'affaires de Sancus	AN
01/03	LES BÉNÉFICES ET LES TRANSACTIONS : Dar Global célèbre une année "exceptionnelle	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ActiveOps sales up; Sancus turnover jumps	24/04
Creo Medical says NHS case study reveals significant efficiencies from Speedboat technology	24/04
EARNINGS AND TRADING: Dar Global celebrates "outstanding" year	01/03
Creo Medical Group plc Announces Microwave Lung Ablation Update	01/03
Creo Medical Group expands reach of Speedboat UltraSlim; announces tie-up with Abu Dhabi university	12/02
Creo Medical ends "pivotal" 2023 year with clear path to cashflow breakeven	12/02
Creo Medical makes "considerable strides" toward 2025 break-even goal	07/02
Creo Medical partners with Khalifa University in Abu Dhabi	05/02
Creo Medical Group plc Announces Strategic Collaboration with Khalifa University of Science and Technology	05/02
Creo unveils product in APAC; Unilever hires director	31/01
Creo Medical Group plc Announces Continued Progress on the Phased Market Release of Its Latest Device, Speedboat® UltraSlim	31/01
Creo Medical's Speedboat UlstraSlim device used in Latin America	10/01
Creo Medical's SpeedBoat UltraSlim successfully used in US	15/12
Creo Medical Group plc Announces First Use of Speedboat UltraSlim in the USA	15/12
Good Energy says ZapMap expands into mainland Europe	13/12
Creo Medical Group PLC Announces the Initiation of Its Commercial Launch of Speedboat Ultraslim	13/12
Creo Medical Group reveals good growth prospects at Capital Markets Day - Proactive Research Analyst	27/11
Creo Medical CEO "very happy with where we are at the moment"	13/11
Creo Medical Wins US FDA Nod for Medical Endoscopy Device	01/11
Creo Medical Group plc Receives 510(K) Clearance from the Us Food & Drug Administration for Its Speedboat Ultraslim Device	01/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Creo Medical Group PLC

Actions

CREO

GB00BZ1BLL44

Autres langues

Filtres